Quarterly report pursuant to Section 13 or 15(d)

ACQUISITIONS AND DIVESTITURES

v3.23.1
ACQUISITIONS AND DIVESTITURES
3 Months Ended
Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
ACQUISITIONS AND DIVESTITURES ACQUISITIONS AND DIVESTITURES
Acquisitions
Our Company’s acquisitions of businesses, equity method investments and nonmarketable securities totaled $20 million and $5 million during the three months ended March 31, 2023 and April 1, 2022, respectively.
Divestitures
Proceeds from disposals of businesses, equity method investments and nonmarketable securities during the three months ended March 31, 2023 and April 1, 2022 totaled $319 million and $218 million, respectively, which primarily related to sales of our ownership interests in certain equity method investees.
Assets and Liabilities Held for Sale
As of December 31, 2022, the Company’s bottling operations in Vietnam met the criteria to be classified as held for sale. As a result, we were required to record their assets and liabilities at the lower of carrying value or fair value less any costs to sell. As the fair value less any costs to sell exceeded the carrying value, the related assets and liabilities were recorded at their carrying value. These assets and liabilities were included in the Bottling Investments operating segment.
In December 2022, the Company received cash proceeds of $823 million in advance of refranchising its bottling operations in Vietnam. This advance was included in the line item accounts payable and accrued expenses in our consolidated balance sheet as of December 31, 2022. The Company refranchised its bottling operations in Vietnam in January 2023 and recognized a net gain of $439 million as a result of the sale, which was recorded in the line item other income (loss) — net in our consolidated statement of income.
The following table presents information related to the major classes of assets and liabilities that were classified as held for sale and were included in the line items prepaid expenses and other current assets and accounts payable and accrued expenses, respectively, in our consolidated balance sheet (in millions):
December 31, 2022
Cash, cash equivalents and short-term investments $ 229 
Trade accounts receivable, less allowances 12 
Inventories 50 
Prepaid expenses and other current assets 43 
Other noncurrent assets 29 
Deferred income tax assets
Property, plant and equipment — net 197 
Goodwill 34 
  Assets held for sale $ 602 
Accounts payable and accrued expenses $ 154 
Accrued income taxes
Other noncurrent liabilities
  Liabilities held for sale $ 160